Chiccem Medical Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-06-2024
- Paid Up Capital ₹ 1.30 Cr
as on 16-06-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 234.92%
(FY 2023)
- Profit 16172.89%
(FY 2023)
- Ebitda 13063.19%
(FY 2023)
- Net Worth 53.49%
(FY 2023)
- Total Assets 35.56%
(FY 2023)
About Chiccem Medical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jiten Desai, Shaileshbhai Nakrani, Chandrakant Kaklotar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74999GJ2018PTC101397
- Company No.
101397
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2018
- Date of AGM
15 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chiccem Medical?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jiten Desai  | Director | 20-Mar-2018 | Current |
| Shaileshbhai Nakrani | Additional Director | 08-Mar-2024 | Current |
| Chandrakant Kaklotar | Additional Director | 17-Aug-2019 | Current |
| Yogesh Mishra | Additional Director | 17-Aug-2019 | Current |
| Parwez Eqbal | Additional Director | 17-Aug-2019 | Current |
| Nitinkumar Kaklotar | Additional Director | 20-Jan-2020 | Current |
Financial Performance of Chiccem Medical.
Chiccem Medical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 234.92% increase. The company also saw a substantial improvement in profitability, with a 16172.89% increase in profit. The company's net worth Soared by an impressive increase of 53.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chiccem Medical?
In 2023, Chiccem Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chiccem Healthcare Private LimitedActive 7 years 8 monthsJiten Desai, Yogesh Mishra and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chiccem Medical?
Unlock and access historical data on people associated with Chiccem Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chiccem Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chiccem Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
